Jessica Rose

And the reason why we went there was because they were about to launch it into the elderly population starting on October 1st. We did reach people. I think that we actually made a difference. They did go ahead with administering these products. Now, this is a COVID SARS product. This has the spike gene inside, and I'll tell you all about that now. In my opinion, it's completely moot.

And the reason why we went there was because they were about to launch it into the elderly population starting on October 1st. We did reach people. I think that we actually made a difference. They did go ahead with administering these products. Now, this is a COVID SARS product. This has the spike gene inside, and I'll tell you all about that now. In my opinion, it's completely moot.

Nobody needs to be injected with this stuff because everybody's had an experience with it and a challenge and or a challenge. But the uptake, the good news is the uptake was apparently quite low. So this is very good news from the point of view of people's awareness having improved.

Nobody needs to be injected with this stuff because everybody's had an experience with it and a challenge and or a challenge. But the uptake, the good news is the uptake was apparently quite low. So this is very good news from the point of view of people's awareness having improved.

However, because of the nature of these products, you know, it kind of makes me wonder if it's not quote unquote too late. So let me tell you what this is and how it's different from the modified mRNA. It does utilize the same lipid nanoparticle technology. The only thing that's different in the formulation that has four fats is the cationic lipid.

However, because of the nature of these products, you know, it kind of makes me wonder if it's not quote unquote too late. So let me tell you what this is and how it's different from the modified mRNA. It does utilize the same lipid nanoparticle technology. The only thing that's different in the formulation that has four fats is the cationic lipid.

So it's still an ionizable cationic lipid, which is the only thing you guys need to know is that it's highly toxic. And those toxicity issues haven't been resolved. So all the compendial standard issues exist. And the good manufacturing practice issues are probably going to carry right over with these new products.

So it's still an ionizable cationic lipid, which is the only thing you guys need to know is that it's highly toxic. And those toxicity issues haven't been resolved. So all the compendial standard issues exist. And the good manufacturing practice issues are probably going to carry right over with these new products.

We know how careful they were with formulating and manufacturing these modified mRNA products. we can see because they have residual DNA in them. So we can assume, I'm speculating here, but we can assume that we're going to have similar problems, at least from the point of view of the lipid nanoparticles with this new stuff. So now let me scare you.

We know how careful they were with formulating and manufacturing these modified mRNA products. we can see because they have residual DNA in them. So we can assume, I'm speculating here, but we can assume that we're going to have similar problems, at least from the point of view of the lipid nanoparticles with this new stuff. So now let me scare you.

What they've done is they've taken something called an alpha virus. This is a genus of viruses in the family Togaviridae. Don't ask me how I remembered that. But these geniuses have borrowed a wonderful tool that these alpha viruses use to self-replicate their own genetic material called an RNA-dependent RNA polymerase.

What they've done is they've taken something called an alpha virus. This is a genus of viruses in the family Togaviridae. Don't ask me how I remembered that. But these geniuses have borrowed a wonderful tool that these alpha viruses use to self-replicate their own genetic material called an RNA-dependent RNA polymerase.

So, like many things in biology, we humans look at them, we marvel at it, and then we try and mimic it in the lab for, like, making therapeutic products. I call it mad scientism. So just like plasmids in bacteria are used in biotech, what these people decided to do was to take this alpha virus and this copying machine enzyme

So, like many things in biology, we humans look at them, we marvel at it, and then we try and mimic it in the lab for, like, making therapeutic products. I call it mad scientism. So just like plasmids in bacteria are used in biotech, what these people decided to do was to take this alpha virus and this copying machine enzyme

extract out the subgenomic components, which are the bits of the alpha virus that it uses to give it infrastructure. By the way, the virus that they used is called Venezuelan equine encephalitis virus, and that's as scary as it sounds.

extract out the subgenomic components, which are the bits of the alpha virus that it uses to give it infrastructure. By the way, the virus that they used is called Venezuelan equine encephalitis virus, and that's as scary as it sounds.

I was going to say, the toga viruses is German measles and equine encephalitis. That's what they cause.

I was going to say, the toga viruses is German measles and equine encephalitis. That's what they cause.

The actual Venezuelan one, yeah, which is the only one we don't have up here in Southern California. We have everything else.

The actual Venezuelan one, yeah, which is the only one we don't have up here in Southern California. We have everything else.